SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-045738
Filing Date
2019-08-13
Accepted
2019-08-13 16:04:56
Documents
1
Period of Report
2019-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3822
  Complete submission text file 0001209191-19-045738.txt   5241
Mailing Address C/O ETON PHARMACEUTICALS, INC. 21925 W FIELD PKWY #235 DEER PARK IL 60010
Business Address
BRYNJELSEN SEAN (Reporting) CIK: 0001669976 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 191020627

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1